European Biotechnology Market Size | COVID-19 Impact Analysis | Forecast to 2026

The European biotechnology market is projected to grow at a significant CAGR of 6.9% during the forecast period (2020-2026). Next-generation sequencing (NGS), also known as high-throughput sequencing, is the catch-all term that is used to describe a number of different modern sequencing technologies such as Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: Proton / PGM sequencing, SOLiD sequencing and so on. These recent technologies allow us to sequence DNA and RNA much more quickly and cheaply than the previously used Sanger sequencing. Such technologies have therefore revolutionized the study of genomics and molecular biology. The advancements in NGS are driving the R&D programs across the region.

To Request a Sample of our Report on European Biotechnology Market: https://www.omrglobal.com/request-sample/european-biotechnology-market

The rising lifestyle-oriented diseases such as CVD, CHD, Cancer, infectious diseases and so on are creating demand for NGS for the R&D process. Technological advancements have led to the introduction of NGS platforms in cancer investigation. NGS allows massive parallel sequencing that affords maximal tumor genomic assessment. NGS approaches are different, and concern DNA and RNA analysis. In recent years, NGS technologies have played a vital role in understanding the altered genetic pathway involved in human cancer. The fact that NGS has a high likelihood of producing results of unknown significance that it has attracted the researchers to explore the cancer disease. 

(Get 15% Discount on Buying this Report)

A full Report of European Biotechnology Market is Available at: https://www.omrglobal.com/industry-reports/european-biotechnology-market

European Biotechnology Market – Segmentation

By Type

·        Healthcare

·        Crop Production and Agriculture

·        Industrial

·        Natural Resources & Environment

·        Others (Bioinformatics) 

European Biotechnology Market – Segmentation by Geography

·        UK

·        Germany

·        France

·        Spain

·        Italy

Rest of Europe

Company Profiles

·        Abbott Laboratories

·        AbbVie Inc.

·        Alere Inc.

·        Alkermes PLC

·        Amgen Inc.

·        AstraZeneca PLC

·        Biogen Inc.

·        Bristol-Myers Squibb Co.

·        CSL Ltd.

·        F. Hoffmann La-Roche Ltd.

·        Johnson & Johnson Services Inc.

·        Novartis AG

·        Novo Nordisk A/S

·        Pfizer Inc.

·        Regeneron Pharmaceuticals, Inc.

·        Sanofi SA

·        Thermo Fisher Scientific Inc.

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-biotechnology-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404